We are analyzing https://link.springer.com/article/10.1007/s10585-007-9065-y.

Title:
Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells | Clinical & Experimental Metastasis
Description:
Src kinase is intimately involved in the control of matrix adhesion and cell migration through its ability to modulate the activity of focal adhesion kinase (FAK). In light of our previous observations that acquisition of tamoxifen resistance in breast cancer cells is accompanied by elevated Src kinase activity, we wish to investigate whether FAK function is also altered in these cells and if this leads to an enhanced migratory phenotype. In in vitro adhesion assays, tamoxifen-resistant (TamR) MCF7 cells had a greater affinity for the matrix proteins fibronectin, laminin, vitronectin and collagen and subsequently demonstrated a much greater migratory capacity across these substrates compared to their weakly-migratory, endocrine-sensitive counterparts. Additionally, elevated levels of activated Src in TamR cells promoted an increase in FAK phosphorylation at Y861 and Y925 and uncoupled FAK activation from an adhesion-dependent process. Inhibition of Src activity using the Src/Abl inhibitor AZD0530 reduced FAK activity, suppressed cell spreading on matrix-coated surfaces and significantly inhibited cell migration. Our data thus suggest that Src kinase plays a central role in the enhanced migratory phenotype that accompanies endocrine resistance through its modulation of FAK signalling and demonstrates the potential use of Src inhibitors as potent suppressors of tumour cell migration.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Telecommunications
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

cas, google, scholar, pubmed, article, src, kinase, adhesion, cancer, cell, focal, cells, fak, migration, activity, res, metastasis, breast, biol, human, phosphorylation, role, mol, csrc, tyrosine, privacy, cookies, content, research, activation, cellular, hiscox, morgan, elevated, signalling, access, schaller, biophys, tumor, data, publish, search, enhances, tamoxifenresistant, march, matrix, migratory, integrin, progression, expression,

Topics {✒️}

integrin-stimulated cell migration month download article/chapter integrin alpha3beta1-dependent activation tamoxifen-resistant mcf-7 cells actomyosin contractility-based invasion transformation-specific tyrosine phosphorylation altered cell–matrix adhesion tetrahydro-2h-pyran-4-yloxy kinase-independent mechanism integrin signalling src-specific phosphorylation site related subjects pdgf-stimulated nih3t3 fibroblasts enhances cellular migration tumour cell migration uncoupled fak activation src family kinases directs sh2-dependent binding breast cancer cells pp60c-src activation focal adhesion kinase full article pdf fak signalling c-src enhances protein tyrosine kinase elevated c-src tumor cell behavior src kinase plays kinase-deficient src human cancer cells alpha2-integrin expression cell migration src sh2 domain human colon cancer adhesion-dependent process privacy choices/manage cookies cancer research mesenchymal transition invasive cell phenotypes accompanies endocrine resistance vitro adhesion assays src activity invasive human tumors src-/- mutant mice increased migratory capacity matrix-coated surfaces biological responses elicited schlaepfer dd signal transduction article hiscox

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells
         description:Src kinase is intimately involved in the control of matrix adhesion and cell migration through its ability to modulate the activity of focal adhesion kinase (FAK). In light of our previous observations that acquisition of tamoxifen resistance in breast cancer cells is accompanied by elevated Src kinase activity, we wish to investigate whether FAK function is also altered in these cells and if this leads to an enhanced migratory phenotype. In in vitro adhesion assays, tamoxifen-resistant (TamR) MCF7 cells had a greater affinity for the matrix proteins fibronectin, laminin, vitronectin and collagen and subsequently demonstrated a much greater migratory capacity across these substrates compared to their weakly-migratory, endocrine-sensitive counterparts. Additionally, elevated levels of activated Src in TamR cells promoted an increase in FAK phosphorylation at Y861 and Y925 and uncoupled FAK activation from an adhesion-dependent process. Inhibition of Src activity using the Src/Abl inhibitor AZD0530 reduced FAK activity, suppressed cell spreading on matrix-coated surfaces and significantly inhibited cell migration. Our data thus suggest that Src kinase plays a central role in the enhanced migratory phenotype that accompanies endocrine resistance through its modulation of FAK signalling and demonstrates the potential use of Src inhibitors as potent suppressors of tumour cell migration.
         datePublished:2007-03-30T00:00:00Z
         dateModified:2007-03-30T00:00:00Z
         pageStart:157
         pageEnd:167
         sameAs:https://doi.org/10.1007/s10585-007-9065-y
         keywords:
            FAK
            Matrix adhesion
            Migration
            Src
            Tamoxifen resistance
            Cancer Research
            Biomedicine
            general
            Oncology
            Hematology
            Surgical Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-007-9065-y/MediaObjects/10585_2007_9065_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-007-9065-y/MediaObjects/10585_2007_9065_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-007-9065-y/MediaObjects/10585_2007_9065_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-007-9065-y/MediaObjects/10585_2007_9065_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-007-9065-y/MediaObjects/10585_2007_9065_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-007-9065-y/MediaObjects/10585_2007_9065_Fig6_HTML.gif
         isPartOf:
            name:Clinical & Experimental Metastasis
            issn:
               1573-7276
               0262-0898
            volumeNumber:24
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Kluwer Academic Publishers
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Stephen Hiscox
               affiliation:
                     name:Welsh School of Pharmacy
                     address:
                        name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, Wales
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Nicola J. Jordan
               affiliation:
                     name:Welsh School of Pharmacy
                     address:
                        name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, Wales
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Liam Morgan
               affiliation:
                     name:Welsh School of Pharmacy
                     address:
                        name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, Wales
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tim P. Green
               affiliation:
                     name:AstraZeneca Pharmaceuticals
                     address:
                        name:AstraZeneca Pharmaceuticals, Macclesfield, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Robert I. Nicholson
               affiliation:
                     name:Welsh School of Pharmacy
                     address:
                        name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, Wales
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells
      description:Src kinase is intimately involved in the control of matrix adhesion and cell migration through its ability to modulate the activity of focal adhesion kinase (FAK). In light of our previous observations that acquisition of tamoxifen resistance in breast cancer cells is accompanied by elevated Src kinase activity, we wish to investigate whether FAK function is also altered in these cells and if this leads to an enhanced migratory phenotype. In in vitro adhesion assays, tamoxifen-resistant (TamR) MCF7 cells had a greater affinity for the matrix proteins fibronectin, laminin, vitronectin and collagen and subsequently demonstrated a much greater migratory capacity across these substrates compared to their weakly-migratory, endocrine-sensitive counterparts. Additionally, elevated levels of activated Src in TamR cells promoted an increase in FAK phosphorylation at Y861 and Y925 and uncoupled FAK activation from an adhesion-dependent process. Inhibition of Src activity using the Src/Abl inhibitor AZD0530 reduced FAK activity, suppressed cell spreading on matrix-coated surfaces and significantly inhibited cell migration. Our data thus suggest that Src kinase plays a central role in the enhanced migratory phenotype that accompanies endocrine resistance through its modulation of FAK signalling and demonstrates the potential use of Src inhibitors as potent suppressors of tumour cell migration.
      datePublished:2007-03-30T00:00:00Z
      dateModified:2007-03-30T00:00:00Z
      pageStart:157
      pageEnd:167
      sameAs:https://doi.org/10.1007/s10585-007-9065-y
      keywords:
         FAK
         Matrix adhesion
         Migration
         Src
         Tamoxifen resistance
         Cancer Research
         Biomedicine
         general
         Oncology
         Hematology
         Surgical Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-007-9065-y/MediaObjects/10585_2007_9065_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-007-9065-y/MediaObjects/10585_2007_9065_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-007-9065-y/MediaObjects/10585_2007_9065_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-007-9065-y/MediaObjects/10585_2007_9065_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-007-9065-y/MediaObjects/10585_2007_9065_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-007-9065-y/MediaObjects/10585_2007_9065_Fig6_HTML.gif
      isPartOf:
         name:Clinical & Experimental Metastasis
         issn:
            1573-7276
            0262-0898
         volumeNumber:24
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Kluwer Academic Publishers
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Stephen Hiscox
            affiliation:
                  name:Welsh School of Pharmacy
                  address:
                     name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, Wales
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Nicola J. Jordan
            affiliation:
                  name:Welsh School of Pharmacy
                  address:
                     name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, Wales
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Liam Morgan
            affiliation:
                  name:Welsh School of Pharmacy
                  address:
                     name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, Wales
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tim P. Green
            affiliation:
                  name:AstraZeneca Pharmaceuticals
                  address:
                     name:AstraZeneca Pharmaceuticals, Macclesfield, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Robert I. Nicholson
            affiliation:
                  name:Welsh School of Pharmacy
                  address:
                     name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, Wales
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Clinical & Experimental Metastasis
      issn:
         1573-7276
         0262-0898
      volumeNumber:24
Organization:
      name:Kluwer Academic Publishers
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Welsh School of Pharmacy
      address:
         name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, Wales
         type:PostalAddress
      name:Welsh School of Pharmacy
      address:
         name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, Wales
         type:PostalAddress
      name:Welsh School of Pharmacy
      address:
         name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, Wales
         type:PostalAddress
      name:AstraZeneca Pharmaceuticals
      address:
         name:AstraZeneca Pharmaceuticals, Macclesfield, UK
         type:PostalAddress
      name:Welsh School of Pharmacy
      address:
         name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, Wales
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Stephen Hiscox
      affiliation:
            name:Welsh School of Pharmacy
            address:
               name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, Wales
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Nicola J. Jordan
      affiliation:
            name:Welsh School of Pharmacy
            address:
               name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, Wales
               type:PostalAddress
            type:Organization
      name:Liam Morgan
      affiliation:
            name:Welsh School of Pharmacy
            address:
               name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, Wales
               type:PostalAddress
            type:Organization
      name:Tim P. Green
      affiliation:
            name:AstraZeneca Pharmaceuticals
            address:
               name:AstraZeneca Pharmaceuticals, Macclesfield, UK
               type:PostalAddress
            type:Organization
      name:Robert I. Nicholson
      affiliation:
            name:Welsh School of Pharmacy
            address:
               name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, Wales
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, Wales
      name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, Wales
      name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, Wales
      name:AstraZeneca Pharmaceuticals, Macclesfield, UK
      name:Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, Wales
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(134)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.93s.

LINK . SPRINGER . COM {}